Testing effectiveness (Phase 2)Study completedNCT03111810
What this trial is testing
Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition
Who this might be right for
Iatrogenic Cushing's Disease
University of Oxford 32